Armstrong Coal Company, Inc. v. Nathan Attebury

Kentucky Supreme Court·Decided August 28, 2017·No. 2016 SC 000368·Unknown

Opinion

IMPORTANT NOTICE NOT TO BE PUBLISHED OPINION

THIS OPINION IS DESIGNATED "NOT TO BE PUBLISHED." PURSUANT TO,JHE RULES OF CIVIL PROCEDURE PROMULGATED BY THE SUPREME COURT, CR 76.28(4)(C), THIS OPINION IS NOT TO BE PUBLISHED AND SHALL NOT BE CITED OR USED AS BINDING PRECEDENT IN ANY OTHER CASE IN ANY COURT OF THIS STATE; HOWEVER, UNPUBLISHED KENTUCKY APPELLATE DECISIONS,· RENDERED AFTER JANUARY 1, 2003, MAY BE CITED FOR CONSIDERATION BY THE COURT IF THERE IS NO PUBLISHED OPINION THAT WOULD ADEQUATELY ADDRESS THE ISSUE BEFORE THE COURT. OPINIONS CITED FOR CONSIDERATION BY THE COURT SHALL BE SET OUT AS AN UNPUBLISHED DECISION IN THE FILED DOCUMENT AND A COPY OF THE ENTIRE DECISION SHALL BE TENDERED ALONG WITH THE DOCUMENT TO THE COURT AND ALL PARTIES TO THE ACTION. RENDERED: APRIL 27, 2017

,ttpttttlt dhturl nf 2016-SC 000368-WC 0 ~I[ · [Q)~ij~5µg(11 KIM~e1,oc ARMSTRONG COAL COMPANY, INC. APPELLANT

ON APPEAL FROM COURT OF APPEALS CASE NO. 2015-CA-001545-WC V. WORKERS' COMPENSATION BOARD NO. 14-WC-90179

NATHAN ATTEBURY; APPELLEES HON. CHRIS DAVIS, ADMINISTRATIVE LAW JUDGE; AND WORKERS' COMPENSATION BOARD

MEMORANDUM OPINION OF THE COURT

.AFFIRMING

An Administrative Law Judge (AW) found that Nathan Attebury

developed toxic encephalopathy and is permanently totally disabled as a result

of exposure to toluene, a chemical in Krylon paint, while working for Armstrong

Coal Company, Inc. The Workers' Compensation Board (the Board) affirmed,

as did a divided panel of the Court of Appeals. On appeal to this Court,

Armstrong argues, as it did below; that the AW's findings were not supported

by evidence of substance. For the following reasons, we disagree and affirm.

I. BACKGROUND.

Attebury was born on June 8, 1981. He has a high schciol education and

his mine-foreman certification, and he has worked as.a construction laborer, in

a clothing factory, and as an underground coalminer. Approximately six months after he started working for Armstrong, Attebury began to experience

headaches, dizziness, short-term me:mory loss, and confusion. His symptoms

progressively worsened, and he stopped working in January 2014.

Attebury testified that he had previously suffered from seasonal affective

disorder, for which he took an anti-depressant, and from panic attacks,

anxiety, and headaches. Attebury also testified that he had been prescribed

Suboxone in order to wean himself from Lortab that he took following a neck

injury.

Attebury first sought treatment for his symptoms with Dr. Jayna Jones

in January 2014. Dr. Jones noted tlJ.at Attebury complained of dizziness,

headaches, memory loss, social anxiety, occasional "blackout spells," and

confusion. Attebury attributed his symptoms to the paint he was using at

work and stated that his symptoms improved when he was off work for any

length of time. Dr. Jones referred Attebury to Dr. Michael Mayron, a

neurologist.

Dr. Mayron, who first treated Attebury on February 17, 2014, noted that

Attebury had ne-µropathy in his left arm and leg, tremors in both hands, and

severe memory impairment. Following his examination and a review of medical

literature, Dr. Mayron made a diagnosis of toxic encephalopathy, which he

attributed to Attebury's exposure to the chemical toluene, a component of the

Krylon spray paint Attebucy used at work. Based on Attebucy's memory loss

and inability to perform multi-step tasks, Dr. Mayron assigned him a 49%

i~pairment rating. In his report and during his deposition, Dr. Mayron

2 referred to an article from the Annals of Neurology from June 1988 to support

his conclusions that Attebury's condition was related to exposure to toluene.

During his deposition; Dr. Mayron stated that he had reviewed other articles,

which he did not have readily available. However, he supplied copies of those

articles to the court reporter after his deposition. We discuss the articles Dr.

Mayron relied on in more detail below.

Armstrong filed the report of Dr. Dennis O'Keefe, a neurologist who

performed an independent medical evaluation of Attebury at Armstrong's

request. In his report, Dr. O'Keefe stated that Attebury complained of

depression, anxiety, headaches, and memory loss that became severe in

December 2013. Dr. O'Keefe's examination revealed deficits in immediate

recall, attention, and calculation; ·an "essentially no,rmal" ability to speak and .

answer questions; and lightheadedness after two minutes of hyperventilation.

Dr. O'Keefe stated that two chemicals in Krylon paint could cause neurological

problems: xylene, which cause.s dizziness, lightheadedness, and other

symptoms; and N-hexane, which causes neuropathyin the extremities. He , noted that Attebury had no symptoms of extremity neuropathy and that

symptoms associated with xylene exposure generally resolve once exposure to

the chemical stops. Based on the preceding, Dr. O'Keefe concluded that

Attebury's symptoms were not related to exposure to chemicals ih Krylon but

to Attebury's depression, which Dr. O'Keefe attributed to "claustrophobia

associated with" working in an underground coalmine.

3 Before the AW, Armstrong argued that Dr. Mayron's opinion regarding

causation was not probative because he: had no history of Attebury's prior

complaints of headaches; relied on literature that pertained "to a different type

of toluene exposure testing in a different type of injury;" and did not know how

much Krylon Attebury used, how he used it, how often he used it, or whether

Attebury had any other exposure to toluene. Armstrong also argued that the

amount of toluene Attebury was exposed to was below OSHA's permissible

limits.

The AW disagreed with Armstrong and found as follows:

On the issue of causation both Dr. Mayron and Dr. O'Keefe have provided an opinion. Both have independently researched the effects of the Krylon paint used by the Plaintiff. Both have concluded that the paint can cause neurological effects. From that point their opinions diverge.

Dr. O'Keefe believes the paint can cause two different types of neurological condition[s]. The first, primarily effecting the limbs, the Plaintiff does not have. The second, according to Dr. O'Keefe, is not permanent and its effects should rc,solve entirely when exposure to th,e paint stops. Dr. O'Keefe affirmatively ·states the Plaintiff does not have toxic encephalopathy, regardless of causation. Dr.. O'Keefe affirmatively states the Plaintiff has no work-related condition.

Dr. Mayron states that one of the potential side effects of the Krylon paint is toxic encephalopathy. This is the diagnosis he makes for the Plaintiff. · He states the toxic encephalopathy is work-related. Dr. Mayron testified in his deposition that he extensively reviewed the Krylon paint, particularly the toluene. It can cause. the toxic encephalopathy and it can cause all of the Plaintiffs neurologic symptoms. The damage is permanent. In short, while I respect both physicians who provided an opinion regarding causation I am more inclined to find the opinion of Dr. Mayron persuasive. He is a treating physician with no known or demonstrated bias. His is a very specific field and area of expertise to which he devotes his practice, i.e. neurological conditions. He has demonstrated the scholarly texts he relies upon.

Free access — add to your briefcase to read the full text and ask questions with AI

Armstrong Coal Company, Inc. v. Nathan Attebury, (Ky. 2017).

Armstrong Coal Company, Inc. v. Nathan Attebury (Armstrong Coal Company, Inc. v. Nathan Attebury) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Ira A. Watson Department Store v. Hamilton
34 S.W.3d 48 (Kentucky Supreme Court, 2000)
Whittaker v. Rowland
998 S.W.2d 479 (Kentucky Supreme Court, 1999)
Johnson v. Commonwealth
12 S.W.3d 258 (Kentucky Supreme Court, 1999)
City of Owensboro v. Adams
136 S.W.3d 446 (Kentucky Supreme Court, 2004)
Toyota Motor Corp. v. Gregory
136 S.W.3d 35 (Kentucky Supreme Court, 2004)
Western Baptist Hospital v. Kelly
827 S.W.2d 685 (Kentucky Supreme Court, 1992)
Wolf Creek Collieries v. Crum
673 S.W.2d 735 (Court of Appeals of Kentucky, 1984)
Shalaby v. Bernzomatic
281 F.R.D. 565 (S.D. California, 2012)